Table 7 Various risk profiles for outcomes in OHS day surgery
Combination | Total N | n of patients | OR (95% CI) | P-value | PPV | NPV | Specificity | Sensitivity |
|---|---|---|---|---|---|---|---|---|
Female & Fentanyl ≥0.16 mg i.v. | 539 | 16 | 6.97 (2.29–21.29) | < 0.001 | 31.3% | 93.9% | 97.8% | 13.5% |
Female & Remifentanil | 542 | 18 | 4.25 (1.33–13.64) | 0.015 | 22.2% | 93.7% | 97.2% | 10.8% |
Fentanyl ≥0.16 mg i.v. & Remifentanil | 539 | 26 | 5.93 (2.31–15.21) | < 0.001 | 26.9% | 94.2% | 96.2% | 18.9% |
Female & Fentanyl ≥0.16 mg i.v. & Remifentanil | 539 | 8 | 15.09 (3.61–63.06) | < 0.001 | 50.0% | 93.8% | 99.2% | 10.8% |
Fentanyl ≥0.16 mg i.v. & General anesthesia | 539 | 30 | 4.86 (1.93–12.23) | < 0.001 | 23.3% | 94.1% | 95.4% | 18.9% |
Fentanyl ≥0.16 mg i.v. & Plexus block | 538 | 18 | 5.87 (1.97–17.47) | 0.001 | 27.8% | 93.8% | 97.4% | 13.5% |
Fentanyl ≥0.16 mg i.v. & Remifentanil & General anesthesia | 539 | 26 | 5.93 (2.31–15.21) | < 0.001 | 26.9% | 94.2% | 96.2% | 18.9% |
Female & Fentanyl ≥0.16 mg i.v. & General anesthesia | 539 | 10 | 10.02 (2.70–37.26) | < 0.001 | 40.0% | 93.8% | 98.8% | 10.8% |
Female & Fentanyl ≥0.16 mg i.v. & Plexus block | 538 | 6 | 14.65 (2.85–75.33) | 0.001 | 50.0% | 93.6% | 99.4% | 8.1% |
Female & Antiemetic medication | 540 | 13 | 6.65 (1.95–22.75) | 0.003 | 30.8% | 93.7% | 98.2% | 10.8% |
Fentanyl ≥0.16 & Antiemetic medication | 539 | 14 | 2.33 (0.50–10.84) | 0.280 | 14.3% | 93.3% | 97.6% | 5.4% |